Elekta's cutting-edge hardware and software innovations are transforming cancer therapy and ushering radiation therapy into
the age of personalized precision medicine
DUBAI, Jan. 25, 2019 /PRNewswire/ --At the Arab Health
Exhibition and Congress, 28-31 January in Dubai, Elekta (EKTA-B.ST) will highlight how the
company is collaborating with hospitals and clinicians in the Middle East and Africa to build better cancer programs for their patients. At booth #S1A30, Elekta will showcase the
company's innovative technologies for delivering precision radiation medicine, including Elekta Unity MR-linac and MOSAIQ®
Plaza.
According to the Health Department of Abu Dhabi, approximately 4,500 new cases of cancer are reported every year in the
United Arab Emirates (UAE). Nevertheless, the country aims to reduce fatalities by 18 percent by
2021, in part through the use of radiation therapy.
"We believe that clinicians and patients in the UAE and around the world should have access to life-saving, world-class cancer
care," said Habib Nehme, Vice President, Middle East and
Africa, Elekta. "Elekta's strategy is to be the partner of choice for delivering cancer
treatment solutions and helping clinicians improve the five-year survival rates in the Middle
East and Africa through our advanced technologies, including expert services, education
and financing. We have currently partnered with several centers of excellence in the region, collaborating on transferring
knowledge and building local competencies that have the potential to improve patient care and outcomes."
Habib adds: "Elekta is increasing its footprint and installed base throughout the Middle East
and Africa, with more than 270 linear accelerators in clinical use, including 24 Leksell
Gamma Knife radiosurgery systems and hundreds of brachytherapy systems. We are also proud to announce we have recently signed an
order for Elekta Unity in Bahrain as well as a contract to deliver an Elekta Unity system to
Algeria. We are dedicated to providing a "one-stop-shop" for cancer and brain disorder solutions
to private and public-sector institutions.
Arab Health attendees are invited to visit the Elekta booth to learn how Elekta is making radiation medicine more accessible,
precise and personalized by improving tumor targeting while protecting the patient. Some of our newest cancer care technologies
include:
- MOSAIQ Plaza, Elekta's newest software solution offering for streamlining and simplifying the delivery of complex precision
radiation medicine treatment regimens.
- Elekta's suite of cutting-edge radiation delivery systems, which are designed to enable complex precision radiation
medicine regimens tailored to each patient's needs:
- Elekta Unity, the first high field magnetic resonance radiation therapy system, which allows clinicians to
see and track difficult-to-visualize soft tissue anatomies during radiation dosing.
- Leksell Gamma Knife® Icon™, the clear choice for intracranial radiosurgery, offers HD motion management
and stereotactic CBCT imaging, allowing for precision radiosurgery with online dose adaptation.
- Versa HD™, a HDRS (High definition dynamic radiosurgery) platform that offers precision and speed to
deliver SRS and SBRT treatments throughout the body in standard treatment time slots.
- Elekta brachytherapy solutions, including Venezia™, a gynecologic brachytherapy applicator designed to
treat advanced cervical cancer.
- IBM Watson for Oncology AI, a powerful tool that augments clinicians' expertise with
evidence-based decision support and provides patients with data-driven care regardless of where they are treated.
*Elekta Unity has CE-mark and 510(k) clearance but is not commercially available in all markets.
For further information, please contact:
Oskar Bosson,
Global EVP Corporate Communications and Investor Relations
Tel: +46-70-410-7180
e-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri,
Global Public Relations Manager
Tel: +1-770-670-2524
e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are
committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized
radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ
Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/elekta/r/elekta-to-showcase-precision-radiation-medicine-for-treating-cancer-at-arab-health-exhibition-and-co,c2725430
The following files are available for download: